1 / 5

Viral Vaccines Market

The Viral Vaccines Market is projected to reach $47.01 billion by 2031, growing at a CAGR of 1.9% from 2024. This market's growth is primarily driven by the increasing government emphasis on immunization programs, technological advancements in vaccine administration, and the use of inactivated vaccines in surgeries and treatments. Additionally, the expansion of biopharmaceutical production capacity, the rising focus on therapeutic vaccines, increased use of adjuvants, growth opportunities in emerging markets, and the development of highly stable, energy-efficient ultra-low-temperature freezers

Prajwal26
Download Presentation

Viral Vaccines Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “Meticulous Research® Projects Hearing Viral Vaccines Market to Reach $47.01 Billion by 2031” pen_spark” J

  2. Viral Vaccines Market 2024-2031 Viral Vaccines Market Poised to Reach $47.01 Billion by 2031, Fueled by Technological Advancements and Expanding Immunization Programs The global viral vaccines market is projected to achieve a valuation of $47.01 billion by 2031, growing at a modest compound annual growth rate (CAGR) of 1.9% from 2024 to 2031, according to the latest report by Meticulous Research®. This growth is primarily driven by a robust product pipeline, heightened government focus on immunization initiatives, and significant technological advancements in vaccine administration. Additionally, the expanding use of inactivated vaccines in surgeries and treatments, alongside the increased capacity for biopharmaceutical production, further supports market expansion. Download Sample Report Here @ https://www.meticulousresearch.com/download- sample-report/cp_id=5920 •Market Dynamics and Opportunities Several factors contribute to the dynamic growth of the viral vaccines market: •Strong Product Pipeline: A diverse array of vaccines is under development, promising to address a wide range of viral infections, thereby bolstering market growth. •Government Immunization Programs: Increasing governmental initiatives worldwide aim to enhance public health through widespread immunization, further driving demand for viral vaccines. •Technological Advancements: Innovations in vaccine administration technologies are streamlining processes, making vaccines more accessible and effective. •Therapeutic Vaccines and Adjuvants: The market is witnessing a growing focus on therapeutic vaccines and the integration of adjuvants to enhance vaccine efficacy. •Emerging Markets: Growth opportunities abound in emerging markets, where the need for effective immunization programs is increasingly recognized. •Ultra-Low Temperature Freezers: The development of highly stable and energy- efficient ultra-low temperature freezers is expected to address logistical challenges, ensuring the safe storage and transportation of vaccines. •Key Market Segments The viral vaccines market is segmented into various categories, including form, vaccine type, virus type, route of administration, approach, indication, application, packaging, and geography. •1. Form •Liquid Vaccines: Expected to hold the largest market share in 2024, liquid vaccines offer ease of administration, reduced risk of errors, and simplified logistics. These advantages, along with growing prevalence of infectious diseases, contribute to the segment's dominance. •2. Vaccine Type Page 1 of 4 © Meticulous Research| sales@meticulousresearch.com

  3. Viral Vaccines Market 2024-2031 •Subunit & Conjugate Vaccines: This segment is projected to account for the largest market share in 2024, attributed to their ability to target pathogens precisely, elicit protective immune responses, and offer long-term immunity with minimal risk of immunogenicity. •3. Virus Type •Adenovirus: Dominating the market in 2024, the adenovirus segment is favored for its efficient gene delivery, strong immune response, and high scalability. Collaborative efforts between institutions and companies are driving advancements in this segment. •4. Route of Administration •Intramuscular (IM), Subcutaneous (SC), Oral, and Other Routes: Various administration routes cater to different patient needs, with each offering unique advantages in vaccine delivery. •5. Approach •Preventive Vaccines: Expected to lead the market in 2024, preventive vaccines are crucial in mitigating the spread of infectious diseases, driven by rising awareness and government-backed immunization programs. •6. Indication •Infectious Diseases: This segment is anticipated to capture the largest share, given the urgent need to prevent life-threatening diseases, reduce mortality rates, and enhance global health security. Companies are intensifying efforts to develop and distribute vaccines targeting infectious diseases. •7. Application •Antisense Therapy: Leading the market in 2024, this segment benefits from the growing prevalence of infectious diseases and technological advancements in viral vectors. Antisense vaccines provide a comprehensive immune response, offering protection against a broad spectrum of pathogens. •8. Packaging •Vials and Prefilled Syringes: Packaging innovations continue to improve vaccine administration efficiency and safety, catering to the evolving needs of healthcare providers. •Geographic Insights •1. North America •Expected to dominate the market in 2024, North America's leadership is driven by advanced research infrastructure, a strong presence of key pharmaceutical companies, and proactive collaboration between research institutes and industry players. The Page 2 of 4 © Meticulous Research| sales@meticulousresearch.com

  4. Viral Vaccines Market 2024-2031 region's heightened awareness of vaccination and preparedness for emerging pandemics further bolster its market position. •Key Industry Players Prominent companies driving the viral vaccines market include: •Pfizer, Inc. (U.S.) •AstraZeneca plc (U.K.) •GlaxoSmithKline plc (U.K.) •Sanofi S.A. (Italy) •CSL Ltd. (Australia) •Mitsubishi Tanabe Pharma Corporation (Japan) •Merck & Co., Inc. (U.S.) •Moderna, Inc. (U.S.) •Johnson & Johnson Services, Inc. (U.S.) •Dynavax Technologies Corporation (U.S.) •Serum Institute of India Pvt. Ltd (India) •Emergent BioSolutions, Inc. (U.S.) •Bharat Biotech International Limited (BBIL) (India) •Valneva SE (France) Read Full Report @ https://www.meticulousresearch.com/product/viral-vaccines- market-5920 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value- driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Page 3 of 4 © Meticulous Research| sales@meticulousresearch.com

  5. Viral Vaccines Market 2024-2031 Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous- research Page 4 of 4 © Meticulous Research| sales@meticulousresearch.com

More Related